Hesperos Inc. logo — The Human-on-a-Chip Company

Hesperos Inc.

The Human-on-a-Chip Company

Founded 2015 United States Orlando, United States 64 employees Grant Total: $5.90M Biotechnology

General Information

Company Name Hesperos Inc.
Founded Year 2015
Location United States Orlando, United States +1
Employees 64
Industries Biotechnology
Funding Stage Grant
Social

Get notified when Hesperos Inc. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Hesperos Inc.

Hesperos Inc. is a biotechnology startup based in the United States, founded in 2015, and has recently received a $1.90M grant investment from the National Institutes of Health on 25 August 2021. The company specializes in accelerating drug discovery by providing safety and efficacy testing of chemicals and novel therapeutics for the pharmaceutical, cosmetic, and food industries using its patented, Human-on-a-Chip platform. Hesperos' innovative technology brings together biologists, surface chemists, and engineers to produce some of the world's most advanced organs-on-a-chip platforms, recreating key components of organs in an interconnected, functional system. Their breakthrough technology enables unprecedented visibility into specific disease states and how the human body will respond to treatment, reducing the need for animal testing in drug discovery while enabling research into previously untreatable rare diseases. The company's functional, interconnected, human in vitro platform provides preclinical insight into the efficacy and toxicity of novel therapeutics, a process that previously required costly animal testing and human trials to determine. Hesperos' Human-on-a-Chip holds the potential to revolutionize the drug discovery process, offering a more ethical, cost-effective, and efficient path to bringing new drugs and treatments to market.

Taxonomy: drug discovery, biomedical engineering, pharmaceutical research, safety testing, efficacy testing, organ-on-a-chip, human biology, preclinical research, in vitro testing

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Grant •••••• 1 •••• •••• 25 Aug 2021
Grant •••••• 1 •••• •••• 27 Sep 2019
Grant •••••• 1 •••• •••• 06 Sep 2018

Hesperos Inc. Alternatives & Competitors

Hesperos Inc. vs

Harness the Power of Fully Functional Human Cells for Innovative Drug Discovery and Therapeutics.

Debt Financing
Biotechnology, Health Care
Hesperos Inc. vs
Altis Biosystems
Altis Biosystems United States

Capturing the Complexity of the Human Gut

Series A
28 employees
Biotechnology, Health Care
Hesperos Inc. vs
NeuCyte
NeuCyte United States

Decoding CNS Drug Discovery with SynFire® iP

Series A
11 employees
Biotechnology, Health Care

FAQ About Hesperos Inc.

The Human-on-a-Chip Company
Hesperos Inc. was founded in 2015.
Hesperos Inc. is headquartered in Orlando, United States.
Hesperos Inc. operates in the following industries: Biotechnology.
Hesperos Inc. has approximately 64 employees.
Hesperos Inc. has completed 3 funding rounds, raising a total of $5.90M. The latest funding stage is Grant.
Top alternatives and competitors to Hesperos Inc. include Cellular Dynamics International, Altis Biosystems, NeuCyte, Emulate, Inc., Eureka Therapeutics, Inc. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Hesperos Inc. and Cellular Dynamics International are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Hesperos Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy